 HACKENSACK, NJ ACCESSWIRE September 13, 2021 Champions Oncology, Inc. Nasdaq:CSBR, leaders in transformative technology solutions utilized in drug discovery and development, today announced its financial results for its first quarter of fiscal 2022, ended July 31, 2021. First Quarter and Recent Highlights: Record quarterly revenue of 11.3 million, an increase of 18 year over year Reported non-GAAP income from operations, excluding stock-based compensation, depreciation and amortization, of 422,000 Validated 6 therapeutic discovery targets Ronnie Morris, CEO of Champions, commented, On our year-end earnings call, we outlined the transformative strategic vision for Champions with the expansion of our services to include a Software as a Service SaaS business and therapeutic target discovery platform. 